US4772475A
(en)
*
|
1985-03-08 |
1988-09-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
Controlled-release multiple units pharmaceutical formulation
|
US5264422A
(en)
*
|
1986-06-30 |
1993-11-23 |
Fidia S.P.A. |
Esters of alginic acid with steroidal alcohols
|
IT1203814B
(it)
*
|
1986-06-30 |
1989-02-23 |
Fidia Farmaceutici |
Esteri dell'acido alginico
|
US5147861A
(en)
*
|
1986-06-30 |
1992-09-15 |
Fidia S.P.A. |
Esters of alginic acid
|
JPH0725689B2
(ja)
*
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
US4956350A
(en)
*
|
1988-08-18 |
1990-09-11 |
Minnesota Mining And Manufacturing Company |
Wound filling compositions
|
US5032384A
(en)
*
|
1989-01-27 |
1991-07-16 |
Block Drug Company, Inc. |
Compositions and method for the treatment of disease
|
IT1229856B
(it)
*
|
1989-04-20 |
1991-09-13 |
Recordati Chem Pharm |
Compresse a rilascio controllato contenenti flavossato.
|
CA1340994C
(en)
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
JPH064531B2
(ja)
*
|
1990-06-04 |
1994-01-19 |
アイセロ化学株式会社 |
大腸崩壊性硬質カプセル
|
ATE135721T1
(de)
*
|
1990-07-26 |
1996-04-15 |
Monsanto Co |
Verfahren zur herstellung vernetzter polyamine
|
US5639738A
(en)
*
|
1992-02-20 |
1997-06-17 |
Hyal Pharmaceutical Corporation |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
|
US5792753A
(en)
*
|
1991-07-03 |
1998-08-11 |
Hyal Pharmaceutical Corporation |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
|
US6103704A
(en)
*
|
1991-07-03 |
2000-08-15 |
Hyal Pharmaceutical Corporation |
Therapeutic methods using hyaluronic acid
|
US5990095A
(en)
*
|
1991-07-03 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US6022866A
(en)
*
|
1991-07-03 |
2000-02-08 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
WO1994007505A1
(en)
*
|
1991-07-03 |
1994-04-14 |
Norpharmco Inc. |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5817644A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Targeting of dosages of medicine and therapeutic agents
|
US5213887A
(en)
*
|
1991-09-03 |
1993-05-25 |
Minnesota Mining And Manufacturing Company |
Antistatic coatings
|
CA2061567C
(en)
*
|
1992-02-20 |
1998-02-03 |
Rudolf E. Falk |
Use of hyaluronic acid to repair ischemia reperfusion damage
|
US6147059A
(en)
*
|
1992-02-20 |
2000-11-14 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6114314A
(en)
*
|
1992-02-21 |
2000-09-05 |
Hyal Pharmaceutical Corp. |
Formulations containing hyaluronic acid
|
FR2694895B1
(fr)
*
|
1992-08-20 |
1994-11-10 |
Coletica |
Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
|
FR2694894B1
(fr)
*
|
1992-08-20 |
1994-11-10 |
Coletica |
Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une substance polyaminée ou polyhydroxylée pour la fabrication de microparticules, procédé et composition.
|
JPH08505402A
(ja)
*
|
1993-08-06 |
1996-06-11 |
ジェイ エムブロ,ウィリアム |
粘膜表皮性及び表皮性の痛み、炎症及び感染症の治療方法及び治療用組成物
|
FR2710265B1
(fr)
*
|
1993-09-22 |
1995-10-20 |
Adir |
Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
|
FR2717687B1
(fr)
*
|
1994-03-24 |
1996-06-14 |
Adir |
Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
|
US5518736A
(en)
*
|
1994-06-27 |
1996-05-21 |
Yissum Research Development Company Of The Hebrew |
Method of preparing natural-oil-containing emulsions and microcapsules and its uses
|
US6150581A
(en)
*
|
1995-06-07 |
2000-11-21 |
United States Surgical Corporation |
Chitosan/alginate anti-adhesion barrier
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
GB2328443B
(en)
*
|
1997-08-21 |
2001-09-05 |
Reckitt & Colmann Prod Ltd |
In situ formation of pharmaceutically acceptable polymeric material
|
AU738512B2
(en)
|
1997-10-03 |
2001-09-20 |
Lavipharm Laboratories, Inc. |
A prolamine-plant polar lipid composition, its method of preparation and applications thereof
|
JP4234803B2
(ja)
*
|
1997-10-27 |
2009-03-04 |
久光製薬株式会社 |
薬物放出速度が制御された医薬組成物
|
NZ529928A
(en)
|
1999-10-29 |
2005-10-28 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
KR101045144B1
(ko)
|
2000-10-30 |
2011-06-30 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
EP1383376A4
(de)
*
|
2001-03-19 |
2006-03-08 |
Praecis Pharm Inc |
Pharmazeutische formulierungen für die anhaltende wirkstofffreigabe
|
US20060198815A1
(en)
*
|
2001-03-19 |
2006-09-07 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
KR20030006788A
(ko)
*
|
2001-07-16 |
2003-01-23 |
이승진 |
치주질환 치료용 서방출성 고분자제제
|
US20040091528A1
(en)
*
|
2002-11-12 |
2004-05-13 |
Yamanouchi Pharma Technologies, Inc. |
Soluble drug extended release system
|
US20040219210A1
(en)
*
|
2003-05-01 |
2004-11-04 |
Jian-Hwa Guo |
Controlled release solid dosage nifedipine formulations
|
DE60319983T2
(de)
*
|
2003-09-01 |
2009-07-23 |
Jpm - The Jordanian Pharmaceutical Manufacturing Co. Ltd. |
Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
|
CA2534483A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Hill's Pet Nutrition, Inc. |
Composition and method for treating bezoar and trichobezoar
|
EP1586313A1
(de)
*
|
2004-04-07 |
2005-10-19 |
The Jordanian Pharmaceutical Manufacturing Co. Ltd. |
Metoclopramid enthaltende pharmazeutische Zubereitungen und Herstellungsmethode
|
ITME20040015A1
(it)
*
|
2004-12-07 |
2005-03-07 |
Vincenzo Savica |
Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
|
EP1685831B1
(de)
*
|
2005-01-19 |
2007-03-07 |
The Jordanian Pharmaceutical Manufacturing Co. Ltd. |
Pharmazeutische Polymerformulierung zur retardierten Freisetzung von Terbutalinsulfat
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
AU2007295894B2
(en)
*
|
2006-09-13 |
2013-10-17 |
Enhance Skin Products, Inc. |
Cosmetic composition for the treatment of skin and methods thereof
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
FR2936952A1
(fr)
*
|
2008-10-09 |
2010-04-16 |
Monique Bellec |
Administration par voie orale de medicaments et complements nutritionnels
|
EP2389167A2
(de)
|
2009-01-20 |
2011-11-30 |
Micro Labs Limited |
Feste pharmazeutische zusammensetzungen aus trimetazidin mit modifizierter freisetzung und verfahren dafür
|
EP2568977A1
(de)
|
2010-05-11 |
2013-03-20 |
Cima Labs Inc. |
Alkoholresistente metoprololhaltige orale retard-dosierformen
|
ES2753198T5
(es)
*
|
2010-12-16 |
2023-05-31 |
Amgen Europe Gmbh |
Formas farmacéuticas orales de liberación controlada de fármacos poco solubles y sus usos
|
US9532977B2
(en)
|
2010-12-16 |
2017-01-03 |
Celgene Corporation |
Controlled release oral dosage forms of poorly soluble drugs and uses thereof
|
US20140044831A1
(en)
*
|
2011-04-20 |
2014-02-13 |
Lars Christian Kure Steenberg |
Chewing Gum Comprising Chitosan For Use In Reduction Of The Level Of Free Phosphorus Compounds In The Digestive Juice
|
CN112370437B
(zh)
*
|
2020-10-20 |
2022-10-21 |
好医生药业集团有限公司 |
一种阿莫西林胶囊及其制备方法
|